Brief: MediPharm Labs Provides Update On Vivo Integration, Board Appointee
April 13 (Reuters) - MediPharm Labs Corp LABS.TO :
* MEDIPHARM LABS PROVIDES UPDATE ON VIVO INTEGRATION AND
BOARD
APPOINTEE
* MEDIPHARM LABS - EXECUTED INITIAL STEPS TO ACHIEVING
POSITIVE
EBITDA SYNERGIES BETWEEN $7M TO $9M ON ANNUALIZED BASIS
* MEDIPHARM LABS - TO REDUCE COMBINED MEDIPHARM AND VIVO
NON-DIRECT LABOUR WORKFORCE BY ABOUT 30%
Source text for Eikon: ID:nCNWZVYvVa
Further company coverage: LABS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medipharm Labs
See all newsCanada's MediPharm Labs Q2 revenue rises 11% on international growth
Brief: MediPharm Labs Q2 Revenue CAD 10 Million
Canada's MediPharm Labs reports positive Q1 adjusted EBITDA
Canada's MediPharm Labs FY revenue rises 8% on international sales
Brief: Medipharm Labs Reports Full Year & Fourth Quarter 2025 Results With Over 40% Annual Growth In International Medical Revenue